EHElizabeth Hente

Elizabeth Hente

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elizabeth Hente has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin A. Hommel

    Division of Behavioral Medicine and Clinical Psychology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA

    8 shared publications
  • Lee A. Denson

    Cincinnati Children's Hospital Medical Center, United States; University of Cincinnati College of Medicine, United States

    6 shared publications
  • Stephanie Spear Filigno

    Division of Pulmonary Medicine, Cincinnati Children's Hospital Cincinnati Ohio USA

    4 shared publications
  • Lisa M. Ingerski

    Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

    3 shared publications
  • Michele Herzer

    Children's Mercy Hospitals and Clinics, Section of Developmental and Behavioral Sciences, Section of Gastroenterology, Kansas City, Missouri

    3 shared publications
  • Thomas Boat

    Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati

    3 shared publications

Latest Publications

  • Longitudinal mental health trends in cystic fibrosis

    by Michelle Hjelm, Elizabeth Hente, Jamie Miller, Susan Moore, James Peugh, David V. Swetland, Dawit G. Tadesse, Monir Hossain, Christopher Siracusa, Stephanie S. Filigno


  • Body composition and functional correlates of CF youth experiencing pulmonary exacerbation and recovery

    by Thomas Boat, Elizabeth Hente, William Hardie, Rhonda Szczesniak, Emrah Gecili, Grace Zhou, Jacqueline Taylor, Raouf Amin

    Background: Youth with cystic fibrosis (CF) and pulmonary exacerbation (PEx) often experience weight loss, then rapid weight gain. Little is known about body composition and its relationship to functional outcomes during this critical period.Methods: Twenty CF youth experiencing PEx were assessed on the day following admission and 7–17 days later at discharge for body mass index (BMI), fat mass index (FMI), lean mass index (LMI), skeletal muscle mass index (SMMI), and functional measures: percent predicted forced expiratory volume in 1 second (FEV1) (ppFEV1), maximal inspiratory and expiratory pressures (MIPs and MEPs), and handgrip strength (HGS). Changes from admission to discharge and correlations among body composition indices and functional measures at both times are reported.Results: Upon admission, participant BMI percentile and ppFEV1 varied from 2 to 97 and 29 to 113, respectively. Thirteen had an LMI below the 25th percentile and nine had a percent body fat above the 75th percentile. BMI and FMI increased significantly (p = 0.03, 0.003) during hospitalization. LMI and SMMI did not change. FEV1 and MIPS increased (p = 0.0003, 0.007), independent of weight gain, during treatment. HGS did not improve.Conclusions: Many youth with CF, independent of BMI, frequently carried a small muscle mass and disproportionate fat at the time of PEx. During hospital treatment, weight gain largely represented fat deposition; muscle mass and strength did not improve. A need for trials of interventions designed to augment muscle mass and function, and limit fat mass accretion, at the time of PEx is suggested by these observations.


  • Assessment of treatment burden and complexity in cystic fibrosis: A quality improvement project

    by Elizabeth Hente, Jeanne Weiland, Lisa Mullen, Jesse Hawke, Christine L. Schuler, Stephanie S. Filigno, Christopher Siracusa

    Background: Treatment regimens for cystic fibrosis (CF) continue to evolve and grow in complexity. Treatment regimen burden, and associated sequelae, are incompletely understood.Objective: Quality improvement (QI) methods were used to investigate treatment burden of CF care, family and care team partnerships, and potential interventions to reduce burden.Methods: Patients 6–24 years with CF and caregivers of patients 6–13 years were surveyed. Portions of validated tools and existing surveys measured burden and family‐care team partnership. An automated report calculated treatment complexity. Plan‐do‐study‐act cycles tested survey administration during CF visits and run charts tracked progress. Interventions to reduce burden were tracked, and bidirectional assessments explored partnerships among patients, families and clinicians.Results: Over 6 months, 110 patients and 62 caregivers completed assessments. Caregivers reported lower burden/higher quality of life (74.0, range 22.2–100) than patients (66.5, range 16.7–100). The mean treatment complexity score was 17.2 (range 6–34). Treatment complexity and burden increased with patient age (p < .05 and p < .01 respectively). Lower lung function correlated with higher patient‐reported burden (p < .01) and higher treatment complexity (p < .0001). As burden increased, providers more often performed select interventions (discussed combining treatments, simplified regimens, or involved other team members (p < .05 for each)). Families reported high partnership (mean scores 4.7–4.8, 5 = high), and providers reported high utilization of partnership tools (tool used in 77% of encounters).Conclusion: We assessed, quantified, and responded to treatment burden and complexity in real‐time during outpatient CF visits. Systematic and individualized assessments of treatment complexity and burden may enhance treatment adherence while preserving quality of life.


  • Sleep disturbance and sleep insufficiency in primary caregivers and their children with cystic fibrosis

    by Kelly C. Byars, Barbara Chini, Elizabeth Hente, Raouf Amin, Thomas Boat


  • A Pilot Study of Mindfulness-Based Cognitive Therapy to Improve Well-Being for Health Professionals Providing Chronic Disease Care

    by Elizabeth Hente, Richard Sears, Sian Cotton, Harini Pallerla, Christopher Siracusa, Stephanie Spear Filigno, Thomas Boat


  • Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement

    by Kelsey Nusbaum, Stephanie S. Filigno, Julie Feldstein, Elizabeth Hente, Elizabeth Koch, Lisa Mullen, Jeanne Weiland, Thomas Boat, Christopher Siracusa

    Background: Pulmonary function tests (PFTs) are performed routinely to evaluate lung function in patients with cystic fibrosis (CF). Staff at the Cincinnati Children's Hospital Medical Center CF Center observed stress in patients before PFTs. An interdisciplinary quality improvement (QI) team was assembled to address this clinical issue.Methods: The Plan‐Do‐Study‐Act method of QI was used to investigate feasibility of assessing stress and offering brief interventions to reduce stress before PFTs. Interventions included listening to music, covering the PFT screen, or doing breathing meditation before PFTs. Patients rated stress levels on a 1 to 5 Likert scale before and after testing.Results: Of 75 patient encounters, interventions were trialed in 20. Fifteen patients who tried an intervention reported wanting to use the intervention again (five encounters had missing data); patients reported that the intervention benefited performance on PFTs in eight encounters (40%). The average pre‐PFT stress rating for encounters that trialed an intervention was 2.1 and post‐PFT rating was 2.0. Average stress pre‐PFT and post‐PFT ratings were 1.7 and 1.6 respectively, for encounters that did not trial an intervention. Median length of PFT encounter was 15 minutes regardless of whether intervention was trialed.Conclusion: Some patients with CF utilized interventions, while many opted out. This QI effort identified feasible outpatient clinic interventions that did not negatively impact clinic flow. Finding ways to reduce stress associated with PFTs could have a meaningful impact on patient performance and emotional well‐being for a subset of patients.


  • Integration of the Safe Environment for Every Kid (SEEK) Model Across Primary Care Settings

    by Emily A. Eismann, Jack Theuerling, Sabine Maguire, Elizabeth A. Hente, Robert A. Shapiro

    This project sought to assess the generalizability, barriers, and facilitators of implementing the Safe Environment for Every Kid (SEEK) model for addressing psychosocial risk factors for maltreatment across multiple primary care settings, including a pediatric practice, federally qualified health center, and family medicine practice. The SEEK model includes screening caregivers for psychosocial risk factors at well-child visits age 0 to 5 years, brief intervention incorporating principles of motivational interviewing to engage caregivers, and referral to treatment. All practices successfully implemented SEEK, with screening completion rates from 75% to 93% and brief intervention rates from 61% to 81%. Major parental stress (14%) and food insecurity (11%) were the most common risk factors. Providers found SEEK worthwhile for improving their knowledge, skills, and ability to address psychosocial concerns and provide whole person care. Barriers included limited time and resources, incomplete resource knowledge, and lack of follow-up. Facilitators included on-site support staff to assist with communication and referrals.


  • The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology

    by Kevin A. Hommel, Wendy N. Gray, Elizabeth Hente, Katherine Loreaux, Richard F. Ittenbach, Michele Maddux, Robert Baldassano, Francisco Sylvester, Wallace Crandall, Charles Doarn, et al.


  • Assessing Psychosocial Risk in Pediatric Inflammatory Bowel Disease

    by Ahna L.H. Pai, Alayna Tackett, Elizabeth A. Hente, Michelle M. Ernst, Lee A. Denson, Kevin A. Hommel

    Aim: The aim of this study was to present the preliminary psychometric properties of the Psychosocial Assessment Tool 2.0_General (PAT2.0_GEN), a brief screener for psychosocial risk in families of children with inflammatory bowel disease (IBD).Methods: Caregivers of 42 youth with IBD were recruited and administered a battery of measures including the PAT2.0_GEN and well‐validated measures of child emotional and behavioral functioning at baseline and at a 6‐month follow‐up.Results: Internal consistency for the PAT2.0_GEN total score was good (α = 0.82). Baseline was significantly associated with the 6‐month follow‐up (r= 0.79,P< 0.001). Significant correlations between the baseline PAT2.0 _GEN total score and caregiver‐reported Child Behavior Checklist total scores at baseline (r= 0.74,P< 0.001) and at a 6‐month follow‐up (r= 0.62,P< 0.001) support the content and predictive validity of the PAT2.0_GEN. Baseline PAT2.0_GEN was also significantly correlated with youth‐reported Child Behavior Checklist total scores at baseline (r= 0.37,P= 0.02) but not at the 6‐month follow‐up (r= 0.23,P= 0.17).Conclusions: A number of indicators support the concurrent and predictive utility of the PAT2.0_GEN. The PAT2.0_GEN is a promising tool for screening psychosocial risk that could facilitate the provision of psychosocial services to those patients most in need.


  • The Clinical Utility of Health-Related Quality of Life Screening in a Pediatric Inflammatory Bowel Disease Clinic

    by Jamie L. Ryan, Michael W. Mellon, Katherine W. F. Junger, Elizabeth A. Hente, Lee A. Denson, Shehzad A. Saeed, Kevin A. Hommel

    Background. Adjusting to symptom flares, treatment regimens, and side effects places youth with inflammatory bowel disease (IBD) at increased risk for emotiona